SCHEMBL8300334

SCHEMBL8300334

CCN1c2ncccc2NC(=O)c2cccnc21

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.50
CYP1A2 P05177 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
CHRM2 P08172 4/20 0.47
LMNA P02545 3/20 0.46
ALDH1A1 P00352 3/20 0.46
CHRM1 P11229 2/20 0.46
USP2 O75604 1/20 0.46
CHRM4 P08173 1/20 0.46
CHRM5 P08912 1/20 0.46
CYP2D6 P10635 1/20 0.46
CHRM3 P20309 1/20 0.46
POLB P06746 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
MAPK1 P28482 1/20 0.45
ADORA2A P29274 1/20 0.45
ADORA1 P30542 1/20 0.45
PDE3A Q14432 1/20 0.45
GMNN O75496 1/20 0.45
APEX1 P27695 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8301869 0.89 CHRM2 (0.48) RAB9ACYP1A2SMN1; SMN2CHRM2LMNA
SCHEMBL9369774 0.87 RAB9A (0.59) RAB9ACYP1A2CHRM2LMNAALDH1A1
SCHEMBL8790717 0.87 RAB9A (0.53) RAB9ACYP1A2SMN1; SMN2CHRM2LMNA
SCHEMBL9704536 0.87 RAB9A (0.42) RAB9ACYP1A2SMN1; SMN2CHRM2LMNA
SCHEMBL9704218 0.86 CYP2C9 (0.47) RAB9ACYP1A2SMN1; SMN2CHRM2LMNA
SCHEMBL9705868 0.86 CYP2C9 (0.45) RAB9ACYP1A2SMN1; SMN2CHRM2LMNA
SCHEMBL4031265 0.85 RAB9A (0.43) RAB9ACYP1A2CHRM2LMNAALDH1A1
SCHEMBL9703875 0.82 CYP2C9 (0.42) RAB9ACYP1A2SMN1; SMN2CHRM2LMNA
SCHEMBL8300867 0.82 RAB9A (0.53) RAB9ACYP1A2SMN1; SMN2CHRM2LMNA
SCHEMBL6959718 0.81 MEN1 (0.43) RAB9ACHRM2LMNAALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0429987-B1 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1999-03-17 EP claimed
EP-0429987-B1 5,11-Dihydro-6H-dipyrido[3,2-b:2',3'-e] [1,4]diazepines and their use in the prevention or treatment of HIV infection BOEHRINGER INGELHEIM PHARMA (US) 1999-03-17 EP disclosed
EP-0482481-A1 Method for the preparation of 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepines BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 1992-04-29 EP disclosed